Last10K.com

Novo Nordisk A S (NVO) SEC Filing 20-F Annual Report for the fiscal year ending Friday, December 31, 2021

SEC Filings

Novo Nordisk A S

CIK: 353278 Ticker: NVO

View differences made from one year to another to evaluate Novo Nordisk A S's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Novo Nordisk A S.

Continue

Assess how Novo Nordisk A S's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Novo Nordisk A S's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Audit Information
Cover
Balance Sheet
Cash Flow Statement
Equity Statement
Income Statement And Statement Of Comprehensive Income
Income Statement And Statement Of Comprehensive Income - Statement Of Comprehensive Income
Basis Of Preparation
Basis Of Preparation (Policies)
Basis Of Preparation (Tables)
Capital Structure And Financial Items
Capital Structure And Financial Items (Tables)
Capital Structure And Financial Items - Borrowings - Contractual Undiscounted Cashflows (Details)
Capital Structure And Financial Items - Borrowings - Narrative (Details)
Capital Structure And Financial Items - Borrowings - Reconciliation Of Liabilities Arising From Financing Activities (Details)
Capital Structure And Financial Items - Cash And Cash Equivalents And Free Cash Flow - Cash And Cash Equivalents (Details)
Capital Structure And Financial Items - Cash And Cash Equivalents And Free Cash Flow - Narrative (Details)
Capital Structure And Financial Items - Change In Working Capital - Change In Working Capital (Details)
Capital Structure And Financial Items - Derivative Financial Instruments - Derivative Financial Instruments (Details)
Capital Structure And Financial Items - Derivative Financial Instruments - Narrative (Details)
Capital Structure And Financial Items - Distributions To Shareholders - Narrative (Details)
Capital Structure And Financial Items - Financial Assets And Liabilities - Fair Value Measurement Hierarchy (Details)
Capital Structure And Financial Items - Financial Assets And Liabilities - Financial Assets By Category (Details)
Capital Structure And Financial Items - Financial Assets And Liabilities - Financial Liabilities By Category (Details)
Capital Structure And Financial Items - Financial Income And Expenses - Financial Expenses (Details)
Capital Structure And Financial Items - Financial Income And Expenses - Financial Impact From Forward Contracts (Details)
Capital Structure And Financial Items - Financial Income And Expenses - Financial Income (Details)
Capital Structure And Financial Items - Financial Risks - Cash And Cash Equivalents And Financial Reserves (Details)
Capital Structure And Financial Items - Financial Risks - Credit Exposure For Cash At Bank, Marketable Securities And Derivative Financial Instruments (Details)
Capital Structure And Financial Items - Financial Risks - Derecognised Receivables (Details)
Capital Structure And Financial Items - Financial Risks - Financial Contracts (Details)
Capital Structure And Financial Items - Financial Risks - Foreign Exchange Sensitivity Analysis (Details)
Capital Structure And Financial Items - Financial Risks - Key Currencies (Details)
Capital Structure And Financial Items - Financial Risks - Narrative (Details)
Capital Structure And Financial Items - Issued Bonds (Details)
Capital Structure And Financial Items - Other Non-Cash Items - Other Non-Cash Items (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Narrative (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Share Capital (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Specification Of Other Reserves (Details)
Capital Structure And Financial Items - Share Capital, Treasury Shares And Other Reserves - Treasury Shares (Details)
Capital Structure And Financial Items -Distributions To Shareholders - Distribution To Shareholders (Details)
Operating Assets And Liabilities
Operating Assets And Liabilities (Tables)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets - Amortisation And Impairment Losses (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets - Narrative (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets And Property, Plant And Equipment (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Intangible Assets And Property, Plant And Equipment - Narrative (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Property, Plant And Equipment - Depreciation And Impairment Losses (Details)
Operating Assets And Liabilities - Intangible Assets And Property, Plant And Equipment - Property, Plant And Equipment - Narrative (Details)
Operating Assets And Liabilities - Inventories - Inventories (Details)
Operating Assets And Liabilities - Inventories - Narrative (Details)
Operating Assets And Liabilities - Leases - Leased Property, Plant And Equipment (Details)
Operating Assets And Liabilities - Leases - Narrative (Details)
Operating Assets And Liabilities - Provisions And Contingent Liabilities - Narrative (Details)
Operating Assets And Liabilities - Provisions And Contingent Liabilities - Provisions (Details)
Operating Assets And Liabilities - Trade Receivables - Trade Receivables (Details)
Other Disclosures
Other Disclosures (Tables)
Other Disclosures - Acquisition Of Businesses - Fair Value Of Recognized Assets And Liabilities (Details)
Other Disclosures - Acquisition Of Businesses - Narrative (Details)
Other Disclosures - Commitments - Contractual Obligations Not Recognised In The Balance Sheet (Details)
Other Disclosures - Commitments - Narrative (Details)
Other Disclosures - Companies In The Novo Nordisk Group (Details)
Other Disclosures - Fee To Statutory Auditors - Fee To Statutory Auditors (Details)
Other Disclosures - Related Party Transactions - Material Transactions With Related Parties (Details)
Other Disclosures - Related Party Transactions - Narrative (Details)
Other Disclosures - Share-Based Payment Schemes - General Terms And Conditions Of Launched Programmes (Details)
Other Disclosures - Share-Based Payment Schemes - Long-Term Share-Based Incentive Programme - Narrative (Details)
Other Disclosures - Share-Based Payment Schemes - Outstanding Restricted Stock Units (Details)
Other Disclosures - Share-Based Payment Schemes - Restricted Stock Units To Employees - Narrative (Details)
Other Disclosures - Share-Based Payment Schemes - Share-Based Payment Expensed In The Income Statement (Details)
Results For The Year
Results For The Year (Tables)
Results For The Year - Earnings Per Share (Details)
Results For The Year - Employee Costs - Employee Costs (Details)
Results For The Year - Employee Costs - Remuneration To Executive Management And Board Of Directors (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Computation Of Effective Tax Rate (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Development In Deferred Income Tax Assets And Liabilities (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Income Taxes Expensed (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Income Taxes Paid (Details)
Results For The Year - Income Taxes And Deferred Income Taxes - Narrative (Details)
Results For The Year - Net Sales And Rebates - Gross-To-Net Sales Reconciliation (Details)
Results For The Year - Net Sales And Rebates - Narrative (Details)
Results For The Year - Research And Development Costs - Research And Development Costs (Details)
Results For The Year - Segment Information - Business Segments - Key Figures (Details)
Results For The Year - Segment Information - Narrative (Details)
Results For The Year - Segment Information - Net Sales - Business Segments And Geographical Areas (Details)
Ticker: NVO
CIK: 353278
Form Type: 20-F Annual Report
Accession Number: 0001628280-22-001639
Submitted to the SEC: Wed Feb 02 2022 9:06:51 AM EST
Accepted by the SEC: Wed Feb 02 2022
Period: Friday, December 31, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nvo/0001628280-22-001639.htm